3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Thyroid cancer, follicular
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Non functioning pancreatic endocrine tumor
1
Neuroendocrine Tumors
1
Liver Neoplasms
1
Carcinoma, Medullary
1
Adenoma, Islet Cell
1
Adenocarcinoma, Follicular
1
Interventions
sodium thiosulfate
2
cabozantinib
1
Restraint, Physical
1
Ramucirumab
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Liver Neoplasms
×
cabozantinib
×
Clear all
NCT01908426
2021-05-06
CELESTIAL
Exelixis
Phase 3
Completed
707 enrolled
20 charts
1 FDA